Cipla Limited has informed the Exchange about General Updates
CIPLA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cipla has submitted to the exchanges the transcript of its 89th Annual General Meeting held on July 16, 2025 through video conferencing. CEO Umang Vohra presented FY25 as the company's strongest year yet, with revenue growing 8%, EBITDA growing 14%, and profit after tax up 28%. The One India franchise grew 7%, North America crossed $934 million, and the Africa and emerging markets businesses grew more than 10%. The company highlighted that it is now net cash positive with about $1 billion in cash on the balance sheet, an ROIC of 33.1%, and R&D investment at 5.6% of revenue. The board declared a final dividend of INR 13 per share plus a special 90th-anniversary dividend of INR 3 per share, taking the total payout to INR 16 per share. Management also discussed progress on the respiratory, mRNA, biosimilar, peptide, and cell therapy pipelines, alongside environmental targets such as net water positive status and 67% renewable energy use at Indian facilities.
The transcript confirms a strong FY25 with record revenue and profits, plus a higher-than-expected total dividend of INR 16 per share that includes a one-time special payout, which should please retail shareholders. The detailed commentary on diversified geographic performance and forward pipeline progress in respiratory, biosimilars, and mRNA is positive for the long-term growth narrative, though no new specific financial guidance was given.